<?xml version="1.0" encoding="UTF-8"?>
<p>The effect of 
 <italic>N. sativa</italic> (1 and 2 g/day for 6- to 12-week duration) supplementation decreased inflammation of the airways and also reversed limitation of airflow, including forced midexpiratory flow (FEF) 25–75% and forced expiratory volume in 1 second (FEV1) % in asthma patients. In addition, 
 <italic>N. sativa</italic> (1 and 2 g/day) significantly improved PEF variability after 6 and 12 weeks of treatment compared to the controls group. The plant also decreased fractional exhaled nitric oxide (FeNO) and serum IgE after 12 weeks of treatment compared to the baseline. 
 <italic>N. Sativa</italic> also increased serum IFN-gamma as well as improved in the asthma control test (ACT) score [
 <xref rid="B127" ref-type="bibr">127</xref>].
</p>
